Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells
Shangwen Jing,1,* Yantong Lu,1,2,* Jing Zhang,1 Yan Ren,1,2 Yousheng Mo,3 Dongdong Liu,3 Lining Duan,4 Zhongyu Yuan,5 Changjun Wang,2 Qi Wang1 1Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China; 2Guangdong Provin...
Main Authors: | Jing S, Lu Y, Zhang J, Ren Y, Mo Y, Liu D, Duan L, Yuan Z, Wang C, Wang Q |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-09-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/levistilide-a-induces-ferroptosis-by-activating-the-nrf2ho-1-signaling-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Levistilide A Exerts a Neuroprotective Effect by Suppressing Glucose Metabolism Reprogramming and Preventing Microglia Polarization Shift: Implications for Parkinson’s Disease
by: Mingjie Zhang, et al.
Published: (2024-02-01) -
Procyanidins Alleviated Cerebral Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the Nrf2/HO-1 Signaling Pathway
by: Lei Chen, et al.
Published: (2023-04-01) -
Therapeutic potential of dihydroartemisinin in mitigating radiation‐induced lung injury: Inhibition of ferroptosis through Nrf2/HO‐1 pathways in mice
by: Xin Ning, et al.
Published: (2024-02-01) -
Metformin induces ferroptosis through the Nrf2/HO-1 signaling in lung cancer
by: Chengmin Deng, et al.
Published: (2023-09-01) -
Icariin inhibits hypoxia/reoxygenation‐induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO‐1 signaling pathway
by: Xiu‐Juan Liu, et al.
Published: (2021-11-01)